Efficacy and safety of lenvatinib combined with PD-1/PD-L1 inhibitors plus Gemox chemotherapy in advanced biliary tract cancer.

Chengpei Zhu,Jingnan Xue,Yunchao Wang,Shanshan Wang,Nan Zhang,Yanyu Wang,Longhao Zhang,Xu Yang,Junyu Long,Xiaobo Yang,Xinting Sang,Haitao Zhao

Frontiers in Immunology（2023）

引用 6|浏览10

暂无评分

摘要

Lenvatinib combined with PD-1/PD-L1 inhibitors and Gemox chemotherapy represents an effective and tolerable treatment option in patients with advanced BTC.

查看译文

关键词

Gemox chemotherapy,PD-1 inhibitor,PD-L1 inhibitor,advanced biliary tract cancer,lenvatinib

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要